AUG 11, 2026 · INTERVENTIONAL STUDY
Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure
ClinicalTrials.gov
This is a clinical trial registry record describing a planned interventional study with no results reported; enrollment is ongoing and primary endpoints have not yet been assessed.
Reported
Planned enrollment2500
Primary effectiveness endpoint ti…Through 24-months follow-up
Primary safety endpoint timeframeWithin 180 days of device implant